RB

Roel Bulthuis

Managing Partner at Syncona Limited

Amsterdam, North Holland

Overview

Work Experience

  • Managing Partner

    2023 - Current

  • Enjoying the sun

    2023 - 2023

  • Managing Director

    2019 - 2023

  • Senior Vice President & Managing Director

    2015 - 2018

    We drive innovation and back entrepreneurs through equity investments and hands on support in fields that could impact the vitality and sustainability of Merck’s current and future businesses. We are the strategic, corporate venture capital arm of Merck. Our mandate is to invest in innovative technologies and products with the potential to significantly impact Merck’s core business areas. From our headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. We take an active role in our portfolio companies and team up with entrepreneurs and co-investors to translate innovation towards commercial success. We have a significant focus on early stage investing and company creation including the creation of spin-offs to leverage Merck’s science and technology base.

  • Senior Vice President & Managing Director

    2009 - 2018

  • Senior Director, Head of Merck Serono Ventures

    2009 - 2015

  • Director, Head of Venture Capital Scouting

    2007 - 2009

  • Associate Director, Corporate M&A

    2006 - 2007

  • Director-Biotechnology Investment Banking

    2000 - 2005

  • Business Development

    2000 - 2000

Relevant Websites